Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin

• Published in: The journal of clinical endocrinology and metabolism 2012-07, Vol.97 (7), p.2380-2387
• Main Authors: Latrofa, Francesco, Ricci, Debora, Montanelli, Lucia, Rocchi, Roberto, Piaggi, Paolo, Sisti, Eleonora, Grasso, Lucia, Basolo, Fulvio, Ugolini, Clara, Pinchera, Aldo, Vitti, Paolo
• Format: Article
• Language: English
• Subjects: Adult; Autoantibodies - blood; Biological and medical sciences; Biopsy, Fine-Needle - methods; Blood Chemical Analysis - methods; Carcinoma; Carcinoma, Papillary; Cytological Techniques; Diagnostic Techniques, Endocrine; Endocrinopathies; Feeding. Feeding behavior; Female; Fundamental and applied biological sciences. Psychology; Humans; Leukemic Infiltration - diagnosis; Leukemic Infiltration - epidemiology; Leukemic Infiltration - pathology; Lymphocytes - pathology; Male; Medical sciences; Middle Aged; Non tumoral diseases. Target tissue resistance. Benign neoplasms; Prognosis; Thyroglobulin - analysis; Thyroglobulin - blood; Thyroglobulin - immunology; Thyroid Cancer, Papillary; Thyroid Neoplasms - blood; Thyroid Neoplasms - diagnosis; Thyroid Neoplasms - epidemiology; Thyroid Neoplasms - pathology; Thyroid. Thyroid axis (diseases); Thyroiditis, Autoimmune - blood; Thyroiditis, Autoimmune - diagnosis; Thyroiditis, Autoimmune - epidemiology; Thyroiditis, Autoimmune - pathology; Vertebrates: anatomy and physiology, studies on body, several organs or systems; Vertebrates: endocrinology
• ISSN: 0021-972X; 1945-7197
• DOI: 10.1210/jc.2011-2812

Context: Serum thyroglobulin (Tg), the marker of residual tumor in papillary thyroid carcinoma, can be underestimated in patients with Tg autoantibodies (TgAb). TgAb are due to a coexistent lymphocytic thyroiditis (LT) or the papillary thyroid carcinoma per se. TgAb assays are highly discordant. Design: We evaluated 141 patients with a clinical diagnosis of nodular thyroid disease, 32 of Hashimoto's thyroiditis, and four of Graves' disease, who underwent total thyroidectomy for an associated papillary thyroid carcinoma. Patients were classified as papillary thyroid carcinoma-lymphocytic thyroiditis (PTC-T) and papillary thyroid carcinoma (PTC) according to the presence or absence of LT on histology. Tg was measured before thyroid remnant ablation, when it is expectedly detectable, by an immunometric assay (IMA) and TgAb by three noncompetitive IMA and three competitive radioimmunoassays (RIA). The number of lymphocytes was compared with TgAb concentration. Results: Seventy-two of 177 patients (40.7%) were classified as PTC-T and 105 (59.3%) as PTC. Although the tumor stage was similar in the two groups, Tg was undetectable in more PTC-T (37 of 72) than PTC (12 of 105) (P < 0.01), and Tg values were lower in the former (0; 0–4.7 ng/ml) (median; 25th to 75th percentiles) than in the latter group (9.7; 2.7–24.2) (P < 0.01). Accordingly, the percent of positive TgAb by the six assays resulted in higher PTC-T (29.2–50.0%) than PTC (1.9–6.7%) (P < 0.01). Among 49 patients with undetectable Tg, TgAb were more frequently positive by IMA (57.1–63.3%) than RIA (30.6–42.9%). The number of lymphocytes correlated with TgAb concentration in all six assays (0.34 < Rho < 0.46) (all P < 0.01). Conclusions: In papillary thyroid carcinoma, LT on histology must be carefully searched for because it is frequently associated with TgAb and therefore mistakenly low or undetectable Tg. TgAb can be missed by some assays. In absence of LT, TgAb are rare.